Sunday, Nov. 22, 2026 A Vik Media Group publication
Mongevity Longevity in Motion
Leer en español

An add-on to GLP-1 drugs helped people keep more muscle while losing weight

☕ Includes a question for the family ↓

GLP-1 drugs (Ozempic, Wegovy, Mounjaro)Part of a story we are following · 8 articles · See every update
A cyclist rides on a paved mountain road among rock formations and pine trees.
A cyclist rides on a paved mountain road among rock formations and pine trees.Photo: Yellowstone National Park / Wikimedia Commons, Public domain

If you are losing weight with GLP-1 drugs, or thinking about it, here is welcome news about your muscle. Researchers have found a way to protect more of it.

In a study of 975 adults with obesity who took the GLP-1 drug semaglutide for weight loss, people who also received the antibody trevogrumab kept more lean mass (mostly muscle) than people who received a placebo. Muscle matters for strength, balance and everyday energy, so this is a real step forward.

Why does muscle loss happen with GLP-1 drugs?

When you lose weight fast, your body does not burn only fat. It also gives up some muscle. GLP-1 drugs such as semaglutide work well for weight loss, and muscle loss comes along with that quick drop.

Your body has natural brakes on muscle growth. Two of them are proteins called GDF8 (also known as myostatin) and activin A. Trevogrumab blocks GDF8. Garetosmab blocks activin A. The idea was simple: ease the brakes, and the muscle holds on better.

How the study worked

The COURAGE trial was a phase 2, randomized, double-blind, placebo-controlled study at 60 sites across the United States. It enrolled 975 adults aged 18 to 80 with obesity. Everyone took semaglutide, and by chance each person also got a placebo or one of the study antibodies, with no one knowing who got what. The results were published on November 11, 2026 in the Lancet. Because this was an early-stage trial of drugs still in testing, the next step is to learn whether keeping this muscle also keeps strength and overall health.

What they found

The study had two parts. In part A, people were treated for 26 weeks. Those taking semaglutide plus a placebo lost lean mass along with their weight. People who added trevogrumab at 200 mg, trevogrumab at 400 mg, or trevogrumab at 400 mg plus garetosmab all ended up with more lean mass than the placebo group. The combination of the two antibodies kept the most.

In part B, people were treated for 52 weeks. Those who added a 75 mg dose of trevogrumab kept more lean mass than the placebo group. A lower 25 mg dose did not show a clear difference.

The weight lost was still mostly fat. In part A, the group that took trevogrumab plus garetosmab lost somewhat more total body weight than the placebo group, and the other groups lost about the same as the placebo group.

Trevogrumab on its own was generally well tolerated, with side effects similar to semaglutide plus placebo. Stomach-related side effects were the most common, and they showed up at similar rates in every group. Most side effects were mild to moderate.

The two-drug combination was a different story. It built the most muscle, but 14 of 149 people (9%) in that group had a serious side effect, and 48 of 149 (32%) stopped treatment. Muscle spasms were also more common, at 61 of 149 people (41%). Two deaths happened in that group, and the researchers did not find that the treatment caused them. The authors concluded that trevogrumab alone is the better-tolerated way to protect lean mass.

What you can do today

This treatment is still being tested, so it is not something you can get at the pharmacy yet. What you can do today is give your muscles a job. Stand up from a sturdy chair and sit back down slowly, five times. Do it again tomorrow, and add it to a daily routine, like right after your morning coffee. Small, steady use is a good way to keep your muscles in the game while you work on your health goals.

Talk about it at home

Muscles are a bit like a team of helpers that stay on the job only when there is work to do. When the body changes quickly, it can let some of that team go, so scientists tested a helper that encourages the body to keep its muscle. They checked by comparing groups of people, so they could be sure the helper was what made the difference.

Stand with your back against a wall, bend your knees as if you were sitting on an invisible chair, and see who in the family can hold it the longest, then tell each other where you feel your muscles working.

Try it at home

Also cited: Lancet

Keep exploring

Copies this article and its questions so you can paste them into ChatGPT, Claude, Gemini or the AI you use, and keep the conversation going.

Got a question? Ask us ›

Get the best of longevity science by emailThe most useful new studies, in plain language and with the source. Free.

We'll email you once to confirm. Occasional messages from our sponsors, clearly labeled. Unsubscribe anytime. We never ask for health data.
Cite this article
AMA
Mongevity Desk. An add-on to GLP-1 drugs helped people keep more muscle while losing weight. Mongevity. Published November 12, 2026. Accessed November 22, 2026. https://mongevity.science/metabolism/2026/11/glp-1-drugs-trevogrumab-keep-muscle-weight-loss/
Vancouver
Mongevity Desk. An add-on to GLP-1 drugs helped people keep more muscle while losing weight [Internet]. Mongevity; 2026 Nov 12 cited 2026 Nov 22]. Available from: https://mongevity.science/metabolism/2026/11/glp-1-drugs-trevogrumab-keep-muscle-weight-loss/
APA
Mongevity Desk. (2026, November 12). An add-on to GLP-1 drugs helped people keep more muscle while losing weight. Mongevity. https://mongevity.science/metabolism/2026/11/glp-1-drugs-trevogrumab-keep-muscle-weight-loss/
For your website
<a href="https://mongevity.science/metabolism/2026/11/glp-1-drugs-trevogrumab-keep-muscle-weight-loss/">An add-on to GLP-1 drugs helped people keep more muscle while losing weight</a>

Free to share or quote with credit and a link.

Questions and answers

Why do people lose muscle on GLP-1 drugs?
Fast weight loss takes some muscle along with fat. GLP-1 drugs such as semaglutide cause quick weight loss, so some lean mass goes too.
What is trevogrumab?
It is an antibody that blocks GDF8 (myostatin), a protein that holds back muscle growth. In this trial it helped people keep more lean mass while taking semaglutide.
Can I get trevogrumab now?
No. It is still being studied. This was a phase 2 trial, an early step before larger studies.
Was the combination with garetosmab better?
It kept the most lean mass, but it had more serious side effects and more people stopped treatment. Trevogrumab alone was better tolerated.

Sources

  1. Lancet: Trevogrumab (anti-GDF8) with or without garetosmab (anti-activin A) for prevention of muscle loss during semaglutide-induced weight reduction in people with obesity (COURAGE): a two-part, phase 2, double-blind, placebo-controlled, randomised trial (PMID 43014326 · DOI 10.1016/s0140-6736(26)01953-7) · 2026-11-12

More on this story

Report an error